EV Biologics Inc (YECO)
0.6021
0.00 (0.00%)
USD |
OTCM |
Apr 18, 16:00
EV Biologics Total Liabilities (Quarterly): 28.89M for Dec. 31, 2017
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2017 | 28.89M |
| December 31, 2016 | 27.91M |
| September 30, 2016 | 27.53M |
| June 30, 2016 | 25.18M |
| March 31, 2016 | 23.01M |
| December 31, 2015 | 20.29M |
| Date | Value |
|---|---|
| September 30, 2015 | 21.46M |
| June 30, 2015 | 30.95M |
| March 31, 2015 | 27.65M |
| December 31, 2014 | 26.01M |
| September 30, 2014 | 37.71M |
| June 30, 2014 | 31.91M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 16.06M |
| AIM ImmunoTech Inc | 9.147M |
| IGC Pharma Inc | 2.206M |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Protalix BioTherapeutics Inc | 50.86M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 31.82M |
| Shareholders Equity (Quarterly) | 2.930M |